Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Romantsov

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Klinicheskaia Meditsina|October 6, 2010
[Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions]Z A Suslina, M G Romantsov, A L Kovalenko, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|March 6, 2010
[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]T V Sologub, A A Shul'diakov, M G Romantsov, et al.
Klinicheskaia Meditsina|April 8, 2010
[Hepatoprotective activity of remaxol in patients with chronic hepatic disorders]T V Sologub, L G Goriacheva, D S Sukhanov, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Klinicheskaia Meditsina|October 6, 2010
[Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions]Z A Suslina, M G Romantsov, A L Kovalenko, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|March 6, 2010
[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]T V Sologub, A A Shul'diakov, M G Romantsov, et al.
Klinicheskaia Meditsina|April 8, 2010
[Hepatoprotective activity of remaxol in patients with chronic hepatic disorders]T V Sologub, L G Goriacheva, D S Sukhanov, et al.
Pageof 9